Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Clinical trial NCT00500500 · TERMINATED

Trial details

NCT number: NCT00500500
Sponsor: Ipsen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2005-07-01
Primary completion: 2008-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.